Kylie is a partner in the Corporate and M&A Group and advises clients on all areas of corporate law.

Kylie focuses on both public and private mergers and acquisitions, joint ventures, private equity investments, corporate advisory matters, corporate restructurings and commercial contract drafting and advice. She advises on both domestic and cross border transactions across a wide range of industries. Kylie also specialises in public corporate governance and securities advisory work for international and domestic publicly listed clients.

Awards and Rankings

• Next Generation Partner, Commercial, Corporate and M&A
• Recommended, Healthcare and Life Sciences

The Legal 500: Europe, Middle East & Africa, 2025

Relevant Experience

• Advising Chanelle Pharma on its sale to Exponent
• Advising ArisGlobal on its acquisition of Sporify
• Advising Capitaland Ascott Trust on its acquisition of the Temple Bar Hotel
• Advising Cyara on its acquisition of Spearline Labs
• Advising Amundi Asset Management on the acquisition of outstanding minority interests in KBI Global Investors
• Advising Goshawk Aviation on its sale to SMBC Aviation Capital
• Advising Cognizant Technology Solutions on its acquisition of TQS Integration Limited
• Advising Novozymes A/S on its acquisition of Precisionbiotics Group Limited
• Advising Total Produce plc on its combination with Dole Food Company, Inc. and the IPO of Dole plc
• Advising on the establishment of the First Home Scheme joint venture between the Department of Housing, AIB, PTSB and BOI